Global X China Biotech Innovation ETF

CHB tracks a market-cap weighted index of Chinese companies that are involved in the biotechnology industry.

CSOP FTSE China A50 ETF

Xtrackers Harvest CSI 300 China A-Shares ETF

Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF

Xtrackers MSCI China A Inclusion Equity ETF

Morgan Stanley China A Share Fund Inc

VanEck China Bond ETF

Direxion Daily CSI 300 China A Share Bear 1X Shares

Direxion Daily CSI 300 China A Share Bull 2X Shares

Global X MSCI China Communication Services ETF

Global X China Energy ETF

Global X MSCI China Health Care ETF

Global X China Industrials

Global X MSCI China Information Technology ETF

Global X MSCI China Large Cap 50 ETF

Global X China Materials ETF

Global X China Consumer ETF

Global X MSCI China Real Estate ETF

Global X MSCI China Consumer Staples ETF

Global X MSCI China Utilities ETF

Global X China Financials ETF

Loncar China Biopharma ETF

Xtrackers MSCI All China Equity ETF

VanEck Vectors ChinaAMC SME-ChiNext ETF

iShares MSCI China A ETF

Invesco China Technology ETF

WisdomTree China ex-State-Owned Enterprises Fund

iShares MSCI China Small-Cap ETF

iShares MSCI Hong Kong ETF

iShares MSCI Taiwan ETF

First Trust China AlphaDEX Fund

Franklin FTSE China ETF

Franklin FTSE Hong Kong ETF

Franklin FTSE Taiwan ETF

First Trust Chindia ETF

iShares China Large-Cap ETF

ProShares UltraShort FTSE China 50

SPDR S&P China ETF

KraneShares MSCI All China Index ETF

KraneShares Bosera MSCI China A Share ETF

KraneShares Bloomberg China Bond Inclusion Index ETF

KraneShares CICC China 5G and Semiconductor Index ETF

KraneShares CICC China Leaders 100 Index ETF

Kraneshares MSCI China Environment Index ETF

KraneShares SSE STAR Market 50 Index ETF

KraneShares Hang Seng Tech Index ETF

KraneShares MSCI All China Health Care Index ETF

KraneShares CSI China Internet ETF

iShares MSCI China ETF

Invesco Golden Dragon China ETF

Rayliant Quantamental China Equity ETF

Franklin Templeton Dragon Fund

ProShares Ultra FTSE China 50

Direxion Daily FTSE China Bear 3X Shares

Direxion Daily FTSE China Bull 3X Shares

ProShares Short FTSE China 50

The most recent macroeconomic figures show that the Chinese slowdown is much more severe than expected and not only attributable to the Covid-19 lockdowns. It is easy to use the Covid-19 lockdowns as the reason for the weakening of the Chinese economy but that would be a gross simplification.

The Chinese Slowdown: Much More Than Covid

Growth opportunities are abounding in Chinese biotech. A confluence of regulatory reforms, industry talent, and the re-opening of the country's capital markets have helped propel China's biotech industry.

Innovation Should Help Fuel Growth in This China Biotech ETF

COVID outbreaks in China have the potential to further disrupt global supply chains and growth rates that equity investors are sensitive to.

COVID In China: DéJà Vu Or Something New?

Why Chinese stocks have been riding a roller coaster of volatility.

Will Chinese Tech Stocks Continue To Face Soaring Volatility?

iShares Agency Bond ETF

SPDR Bloomberg 1-3 Month T-Bill ETF

Barclays Bank iPath US Treasury 5-Year Bear Exchange Traded   Note 2011-12.7.21 Ser -A- Lkd to BC 2Y US Trsry Futs Trgtd Expsre

Barclays Bank iPath US Treasury 2-year Bull Exchange Traded   Notes 2010-13.8.20 Ser -A- Lnk to BC 2Y US Treasury Futures Trg Ex

Barclays Bank iPath US Treasury 2 Yr Bear Exchange Traded

Barclays Bank iPath US Treasury 10 Yr Bull Exchange Traded    Notes 2010-13.8.20 Sr-A Lk Barclays Cap 10Y US Trs Fut Trgt Exp Id

Vanguard Extended Duration Treasury ETF

BlackRock Enhanced Government Fund

iShares U.S. Fixed Income Balanced Risk Factor ETF

Franklin Short Duration U.S. Government ETF

Goldman Sachs TreasuryAccess 0-1 Year ETF

iShares U.S. Treasury Bond ETF

iShares 25+ Year Treasury STRIPS Bond ETF

Invesco Ultra Short Duration ETF

iShares 7-10 Year Treasury Bond ETF

iShares 3-7 Year Treasury Bond ETF

First Trust Long Duration Opportunities ETF

First Trust Low Duration Opportunities ETF

Invesco 1-30 Laddered Treasury ETF

ProShares UltraShort 7-10 Year Treasury

ProShares Inflation Expectations ETF

Schwab Short-Term US Treasury ETF

Schwab Long-Term US Treasury ETF

Schwab Intermediate-Term US Treasury ETF

iShares Short Treasury Bond ETF

iShares 1-3 Year Treasury Bond ETF

SPDR Portfolio Long Term Treasury ETF

SPDR Portfolio Short Term Treasury ETF

Barclays Inverse US Treasury Composite ETN

Proshares Short 20+ Year Treasury

ProShares UltraShort 20+ Year Treasury

ProShares Short 7-10 Year Treasury

iShares 10-20 Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Direxion Daily 20+ Year Treasury Bull 3X Shares

Direxion Daily 20+ Year Treasury Bear 3X Shares

ProShares UltraPro Short 20+ Year Treasury

Direxion Daily 7-10 Year Treasury Bull 3x Shares

Direxion Daily 7-10 Year Treasury Bear 3x Shares

ProShares Ultra 20+ Year Treasury

Invesco DB US Dollar Index Bearish Fund

WisdomTree Bloomberg US Dollar Bullish Fund

ProShares Ultra 7-10 Year Treasury

Invesco DB US Dollar Index Bullish Fund

Vanguard Intermediate-Term Treasury ETF

Vanguard Long-Term Treasury ETF

Vanguard Short-Term Treasury ETF

PIMCO 25+ Year Zero Coupon US Treasury Index ETF

The deficit spending that supported the economy in 2020 is showing up in hot inflation numbers in 2021. While I think the inflation numbers will get better in 2022, I do not believe they will get back to pre-pandemic levels because of owners' equivalent rents and wage gains in the CPI.

Mind The Bond Market

China has not solved the unravelling crisis in its development/construction sector. The nation has moved through all the ‘natural' stages an economy goes through when implementing the free market capitalism model.

China's Next Phase Can Make You Money Or Steal Your Savings

The bankruptcy of the Chinese real estate company Evergrande is much more than a “Chinese Lehman”. The implications of an Evergrande collapse are far greater than what investment banks tell us.

Evergrande Isn't China's 'Lehman Moment.' It Could Be Worse Than That

Chinese government has generally had some idea of how much risk Evergrande and other highly leveraged real estate companies pose since last year. Equity holders will most likely be wiped out, with holders of bond and wealth management products taking significant haircuts.

What's The Likely End For Evergrande?

The impact of the policy remedy to China's property market excesses is spreading across global markets. But they would bounce hard on any evidence of a mitigation plan from Beijing.

The World Sweats During China's Vacation

iShares MSCI All Country Asia ex Japan ETF

VanEck Vectors Africa Index ETF

Central and Eastern Europe Fund

China Fund

Morgan Stanley Exch Traded Nts 2008-31.3.20 Ser-F Linked to S&P Chinese Renminbi TR Ind

Direxion Daily CSI China Internet Index Bull 2X Shares

WisdomTree Chinese Yuan Strategy Fund

iShares MSCI Japan ETF

iShares Latin America 40 ETF

KraneShares MSCI One Belt One Road Index ETF

SPDR S&P 500 ETF Trust

Vanguard FTSE Europe ETF

Vanguard Total World Stock ETF

SPDR Solactive Hong Kong ETF

Shares in China continue to post sharp year-to-date losses vs. an otherwise upside bias for global stocks, based on a set of exchange-traded funds tracking the world's major equity regions through yesterday's close (Aug. 25). Some investors see opportunity in beaten-down shares, but there's still a wide-ranging debate as the market prices in higher uncertainty driven by the vagaries of Beijing's evolving policy agenda.

China Is This Year's Downside Outlier For Global Stock Markets

As China continues to lead the global recovery, one area to keep a close eye on is biotechnology and the Global X China Biotech Innovation ETF (CHB). CHB seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index.

The CHB ETF: China's Burgeoning Biotech Sector

First Trust Health Care AlphaDEX Fund

iShares Evolved U.S. Healthcare Staples ETF

iShares U.S. Medical Devices ETF

Invesco S&P 500 Equal Weight Health Care ETF

UnitedHealth Group

Health Care Select Sector SPDR Fund

Decent earnings growth picture and valuation as well as solid deals activities have been favoring healthcare sector at the current level.

Are Healthcare ETFs Poised for a Comeback?

Alerian MLP ETF

JPMorgan Municipal ETF

iShares Broad USD Investment Grade Corporate Bond ETF

Vanguard U.S. Liquidity Factor ETF

SmartETFs Asia Pacific Dividend Builder ETF

SmartETFs Dividend Builder ETF

Plus, iShares lowered expense ratios on two of its ETFs.

ETF Odds & Ends: First Mutual Fund Conversion

BeiGene

Novartis

Roche Holding AG

Healthcare was the second-best performing sector in China in 2020.

China Healthcare: A Rediscovered Sector Keeps Its Momentum

AbbVie

Royalty Pharma

Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist. The post 3 Biotech Stocks With Eye-Catching Pipelines appeared first on InvestorPlace.

3 Biotech Stocks With Eye-Catching Pipelines

All around the world, economic superpowers are vying to be the first to develop a vaccine for Covid-19. China is an obvious contender given that the country was the epicenter of the virus and their success, if attained, could help boost certain exchange-traded funds (ETFs).

China's Quest for a Covid-19 Vaccine Could Help Boost This ETF

With the rise of the broader health care sector, China's biotech industry is already among one of the fastest-growing in the world and is expected to mature from its infancy to a global leader.

Introducing The Global X China Biotech Innovation ETF

News for Global X China Biotech Innovation ETF ETF (CHB)